The catalytic domain of protein kinase C chimeras modulates the affinity and targeting of phorbol ester-induced translocation

Abstract

Emerging evidence suggests important differences among protein kinase C (PKC) isozymes in terms of their regulation and biological functions. PKC is regulated by multiple interdependent mechanisms, including enzymatic activation, translocation of the enzyme in response to activation, phosphorylation, and proteolysis. As part of our ongoing studies to define the factors contributing to the specificity of PKC isozymes, we prepared chimeras between the catalytic and regulatory domains of PKCα, -δ, and - ε. These chimeras, which preserve the overall structure of the native PKC enzymes, were stably expressed in NIH 3T3 fibroblasts. Their intracellular distribution was similar to that of the endogenous enzymes, and they responded with translocation upon treatment with phorbol 12-myristate 13- acetate (PMA). We found that the potency of PMA for translocation of the PKCα/x chimeras from the soluble fraction was influenced by the catalytic domain. The ED50 for translocation of PKCα/α was 26 nM, in marked contrast to the ED50 of 0.9 nM in the case of the PKCα/ε chimera. In addition to this increase in potency, the site of translocation was also changed; the PKCα/ε chimera translocated mainly into the cytoskeletal fraction. PKCx/ε chimeras displayed twin isoforms with different mobilities on Western blots. PMA treatment increased the proportion of the higher mobility isoform. The two PKCx/ε isoforms differed in their localization; moreover, their localization pattern depended on the regulatory domain. Our results emphasize the complex contributions of the regulatory and catalytic domains to the overall behavior of PKC.